Our research group has conducted a comprehensive and long-term investigation into the role and underlying mechanism of β-estradiol (E2, one of the three primary oestrogens) and oestrogen receptor beta (ERβ) in the development of non-small cell lung cancer (NSCLC) [14–16]. This evidence concerns the gene ESR2 and non-small cell lung carcinoma.